Prohibition at the Calgary Stampede

Posted by on in Cannabis | Comments Off on Prohibition at the Calgary Stampede

Prohibition at the Calgary Stampede

Prohibition at the Calgary Stampede

I was given the amazing opportunity to attend a work conference held at the Calgary Airport in one of their swanky onsite hotels.  We headed West with epic timing with the Calgary Stampede opening that weekend to which we were all eager and determined to attend.  I’ve always been a horse-lover but was excited for the crazy eats!  It was choking to get to the gate to be turned away by the twelve year-old in the ten-gallon hat who told me my medical Cannabis was prohibited from the fairgrounds~Stampede Policy!

 I felt angry like Clark Griswold, ready to punch a Moose.

I told my friends to go in and have fun and loudly told the little prick that I was goin’ to smoke some weed!  Little did I know that the fun was on the outside of the gates!  I sat and watched shiny limo’s and shit-speckled trucks pass by dropping off and picking up people in boots and hats.  I sat on a hill and rolled two shoddy doobies with vibrating hands, shielding my precious from the breeze.  No one batted an eye!  One young drunk cutie told me he liked what I was doin’ as he ran past me to pee behind a tree.  He of course was allowed in the gates, after he was done peeing that is.

The perception that the measly four grams of cannabis in my purse is somehow dangerous or suspect is outdated thinking so I asked one of the Police officers if I was allowed in.  She confirmed it.  So I sat and smoked til the stewing stopped and giggled at the beauty around me.  THC lowers the negative and within half an hour I had come to a decision:  we have one year to change Calgary Stampede Policy and outdated thinking.  

I’m puttin’ it out into the universe:  I’ll be vaping in the lounge next year at Stampede 2018!

As I sat on the hill vaping and watching public displays of intoxication all around me, I wondered how many other patients would be turned away as I was.  Today, a week later I see an article about another patient who had more gumption than I did and spent a few hours talking to the security and police about her right to enter the grounds.  She finally won but was asked not to smoke it while on the grounds.  Oh no, we wouldn’t want any of the underage drinkers to catch a whiff.

All I wanted to do was have a real Alberta Beef burger to see what all the fuss is about and because I use a plant as medicine, I was kept out of the fun.  From a capitalistic standpoint, this outdated thinking doesn’t jive with reality.  My friends who went in couldn’t stop talking about all of the food vendors!  Cannabinoids encourage the appetite;  allowing us in would be good for sales!  Now all I want to do is have a conversation with whomever makes the Calgary Stampede Policy.  We gotta update some things.

New rules:  

  1. Legal Cannabis permitted and welcome with smoking areas provided.  
  2. No more Chuckwagon races!


The Ultimate Setup Guide for a Cannabis Grow Box

Posted by on in Cannabis | Comments Off on The Ultimate Setup Guide for a Cannabis Grow Box

The Ultimate Setup Guide for a Cannabis Grow Box

The Ultimate Setup Guide for a Cannabis Grow Box

So you’ve always wanted to grow your own cannabis instead of buying it?

Then you’ve come to the right place.

Growing your very own ‘ganja’ is quite simple and the success rate is fairly high, even when you’re just starting out.

Want to know more?

You can grow cannabis in two different ways:

1) Setup a grow room

2) Setup a grow box

In this guide, we will walk you through every step you need to take in order to successfully grow your own cannabis with a grow box!

Let’s get started..

Weather conditions have a significant effect on your cannabis production in case you plan to keep your grow box outside.

This could be a major disadvantage and might limit your yield. However, a grow box is relatively small and perfect to keep indoors. When you want to grow cannabis in a grow box, you want to pay attention to: lights, water, humidity, ventilation and temperature. All mentioned factors are in your control and can be optimized in order to perfectionate production conditions, resulting in quality cannabis!

canna seeds

What do you need?

Obviously, you don’t need a whole lot of equipment to build a grow box. When it comes to a grow box, you have three options:

  1. Build a wooden box yourself
  2. Buy a “grow tent”

That’s all? No….

You’ll also need a grow lamp, a fan, and a clock. Based upon your own situation, you might have to consider buying a filter against the smell. You also want to measure a thing or two with a thermometer and hygrometer.

What do you want to accomplish?

The fundamental goal is to optimize the photosynthesis of your plants. By creating a perfect environment for your plants to grow, you can positively influence this process. In other words: better photosynthesis is better quality. We call this optimizing the yield. The better you do this, the better your joint will be!

1. Grow Box

The dimensions of your grow box are variable. Just build one that’s big enough to house all equipment but isn’t too big for your place.

Make sure to create air holes. It would be best to have separate locations for incoming (fresh air) and outgoing air. Then you want to locate a thermometer and hygrometer on a spot where you can clearly see determine temperature and humidity.

Important: When you install and place the required electronics on your grow box, do not just attach it to the wooden outside of the box. Installing the electronics has to be done with precision and care in order to minimize the risk of fire.

2. Grow Lights

Your plants need light in order to produce chemical energy, hence the grow lamp you’ll need. With a grow lamp you can establish control over the “day and night”, which is very important as your plants need hours of light and darkness: 18 hours of light and 6 hours of darkness in the vegetative stage, 12 hours of light and 12 hours of darkness in the flowering stage.

At this point you have two lighting options:

  1. LED
  2. HPS (High Pressure Sodium)

For the first stage, mentioned above, you will need 400-Watt HPS lamps. For the second stage, you will need 600-Watt HPS. Due to sodium in HPS lamps, lifespan is limited. Only when you can afford LED lamps, go for it. LED lamps have a significantly longer timespan. However, if this is your first grow experience, forget about LED and get yourself a HPS lamp.

Extra tip:

It’s best to have reflective walls, preferably white. Very dark or black walls absorb light which affects the quality of the yield. Simply paint the inside of your grow box white or even better, use white foil for optimal reflection.

mari leaf

3. Ventilation and Air Circulation

When you can’t allow to have smell around, make sure your box is impenetrable of smell. A must-have is a carbon filter for all outgoing air to pass through in order to sustain proper air circulation and fresh air. You can regulate temperatures by installing a fan.

Plants live and grow by consuming sugar. Plants produce sugar through converting CO2 into oxygen and sugars. Therefore, make sure to create some openings for fresh air circulation.

4. Watering and Humidity

In order to maximize yield, you want to have the right humidity level. When the humidity level is too high, mold and fungus will appear on your plants and equipment causing damage. Both seedlings and cuttings require unique humidity levels all the way till the growing and blooming phase. In addition, there’s variation between plants in regards to humidity so conduct some research so you know what’s best for your plants.grow (Source: http://www.thenug.com/sites/default/pub/041214/pic1.png)

5. Temperature

As mentioned before, installing an air extractor enables you to regulate temperatures. This is important in order to avoid your plants from being overheated.

Temperature control is an important factor for the quality of your yield. It’s an essential factor for optimal photosynthesis and ultimately successful growth of your plants. Pay attention to the combination of temperature and lighting. As for most of us in daily life, temperatures are higher during daytime in comparison to nighttime.

Apply an identical environment for your plants. You ideally want to maintain a temperature of 77 °F / 25°C during daytime. Never have box temperature under 64°F / 17.8°C during nighttime.

It’s important to remember that you will gain more and more experience along the way as an individual production grower, and have a better understanding of the unique needs of your plants over time.disp

6. Carbon Filter (Optional)

In order to prevent the smell of cannabis spreading around your house, it is recommended to buy the earlier mentioned carbon filter. Anticipate on any scenario that could bring harm to your plants or facility.

Establishing your very own grow box brings many challenges but also provides a unique experience. It’s also a perfect learning opportunity! A perfect environment and combination of temperature, humidity, air circulation and lighting will have an immense impact on the quality and quantity of the yield.

Are you ready to start growing?

Let us know below in the comments if you have any problems! We are here to help you!

Happy growing 🙂

(Why?)

Published at Sat, 15 Jul 2017 18:00:35 +0000

Read More

Will this be the year Congress expands veterans' access to medical marijuana?

Posted by on in Cannabis | Comments Off on Will this be the year Congress expands veterans' access to medical marijuana?

Will this be the year Congress expands veterans' access to medical marijuana?

Will this be the year Congress expands veterans' access to medical marijuana?

The U.S. Senate Appropriations Committee on Thursday amended must-pass legislation to add language expanding access to medical marijuana for military veterans.

Again.

The Veterans Equal Access Amendment to the 2018 Military Construction, Veterans Affairs and Related Agencies Appropriations Bill would prohibit federal funds from interfering with a veteran’s ability to take part in medical marijuana programs approved by states where cannabis is legal. It would also allow Department of Veterans Affairs (VA) doctors in those legal states to “make appropriate recommendations, fill out forms, or take steps to comply with such a program.” An identical amendment is expected to receive a vote in the house version of the bill later this year.

Both the House and Senate passed a similar amendment last year. But that provision, as the Military Times reported in June 2017, “disappeared mysteriously” from the final VA funding bill after Republicans removed it during a concurrence vote.

Whether the latest 24-to-7 vote in favor of the amendment is lip service or a sign of larger policy changes in the works remains to be seen.

The amendment has the support of powerful veterans organizations, including The American Legion. The nation’s largest veterans service group supports additional legislative steps to expedite its passage into law, said spokesman Joe Plenzler.

“The House and the Senate have attempted to do this over the past two years, yet each time the conference committee has failed to reconcile the language relating to this initiative,” he said. “The American Legion would like to see the language of this bill reconciled before submission so it doesn’t have to go to the committee.”

Other veterans’ cannabis advocacy groups, still bitter from last year’s outcome, are holding a hard line.

“It is my position that any member of the House or Senate who votes against this amendment is no friend of veterans,” said Roger Martin, founder of Grow for Vets USA, a Las Vegas-based non-profit that gives away medical cannabis to veterans.

Enthusiasm for the passage of this amendment is “muted” by the fact that the same language was stripped out of last year’s appropriation despite passing by impressive margins in both the House and the Senate, Martin said.

That sentiment was echoed by Sean Kiernan, president of Weed For Warriors, a California-based nonprofit educating vets on the benefits of medical marijuana.

“We have been here before, then magically the amendment disappeared in reconciliation after both the House and Senate had passed it,” he told The Cannabist. “Why should getting it out of appropriations (committee) give veterans hope?”

But Nick Etten, the founder and executive director of the Veterans Cannabis Project, said his organization took heart in the “strong action” taken by the senate appropriations committee.

“Healing from the wounds of war requires effective treatment options, and medical cannabis is a proven, safe and responsible choice for veterans,” he told The Cannabist.

There are nearly 19 million veterans, many of whom survived their service only to return to civilian life with battle scars seen and unseen. An increasing number of those vets — and the groups that support them — are demanding safe access to medical marijuana to treat traumatic brain injury (TBI), post-traumatic stress disorder (PTSD) and other physical and mental afflictions.

The VA has no position on the appropriations amendment, a spokesperson told The Cannabist.

The VA “is required to follow all federal laws regarding marijuana use,” the agency states on its website. That means the healthcare system’s clinicians cannot prescribe medical cannabis to their patients or complete any of the forms required for vets to take part in medical marijuana programs in states that have legalized it.

In his May “State of the VA” address, Veterans Affairs Secretary David Shulkin made the agency’s position clear. “Until the time that federal law changes,” he said, “we are not able to be able to prescribe medical marijuana for conditions that may be helpful.”

The Veterans Equal Access amendment is meaningful if only because it has the potential to remove the stigma surrounding medical marijuana, said Adam Foster, an attorney with Denver’s Hoban Law Group. Earlier this year he was part of a team that successfully lobbied to get PTSD listed as a qualifying condition for medical marijuana in Colorado.

“If veterans are getting treatment through the VA, we want them to be able to be honest with their VA doctor so they can get a comprehensive treatment plan that could include medical cannabis as well as pharmaceutical drugs,” he told The Cannabist. “That’s why we want VA doctors to become more educated about cannabis, the endocannabinoid system and how cannabis can compliment other drugs.”

The ability to be honest with their doctors about medical marijuana is also critical if those patients are to be weaned off addictive prescription drugs, he emphasized.

The risk of veterans dying by suicide is significantly higher than that of the adult civilian population, according to a recent report from the VA using 2014 data that shows as many as 20 military veterans take their own lives daily.

But Grow for Vets’ Martin previously told The Cannabist that the VA statistics don’t tell the whole story. He estimates that more than 1 million vets are currently taking opiates, most of which were obtained from VA facilities. As a result, he said, many veterans are dependent on pharmaceuticals and at a greater risk of overdose or suicide. He estimates that more than 50 vets a day die from prescription drug overdoses and suicide.

“This is but one more glaring example of how large pharmaceutical companies negatively influence our lives by stuffing billions of dollars into politicians’ election campaigns,” he said of legislators’ reticence to pass The Veterans Equal Access Amendment into law.

But attorney Foster remains optimistic that the arguments against medical marijuana are becoming less politically divided.

He points out that the new appropriations amendment was bipartisan, co-sponsored by Sen. Steve Daines (R-Montana) and Sen. Jeff Merkley (D-Oregon). He also hailed bipartisan efforts to reclassify cannabis under the Controlled Substances Act.

Introduced in April by two Florida congressmen, Republican Rep. Matt Gaetz and Democratic Rep. Darren Soto, House Bill 2020 would reclassify cannabis from Schedule I to Schedule III, allowing for banking activities and creating a clearer path for research.

The American Legion also advocates rescheduling cannabis so that more research can be done on its potential medical benefits. Earlier this week, the group expressed its support of the legislation in a letter to Rep. Gaetz that was also shared with The Cannabist.

Rescheduling cannabis would enable medical research into the efficacy of cannabis in treating PTSD, TBI, chronic pain and other afflictions that veterans face every day as a result of their combat service, Charles E. Schmidt, American Legion National Commander wrote.

“With 90 percent of Americans supporting legalization of medical marijuana today, it is time for Congress to act so that scientists are free to conduct advanced research into cannabis and PTSD/TBI, and enable the American people to have a fact-based discussion about the therapeutic value of cannabis. The lives of our veterans depend on it.”

(Why?)

Published at Fri, 14 Jul 2017 21:21:19 +0000

Read More

The Cannabis Bubble

Posted by on in Cannabis | Comments Off on The Cannabis Bubble

The Cannabis Bubble

The Cannabis Bubble

Everybody wants in on cannabis riches. With more states legalizing and Canada set for commercial sales in 2018, the future looks bright.

But what about the inevitable economic slow-down?

The cannabis industry is one among many currently experiencing an inflationary boom.

There is a burst of entrepreneur creativity in the cannabis industry, and as this develops and matures, as time goes on, many of these ideas will be honed in and consolidated.

This happens naturally, but an economic bust necessitates that this happens abruptly, in a way that makes some people poorer by revealing actions that are detrimental to wealth creation.

Without easy access to credit, many cannabis companies will end up like the bankrupt companies of the dot-com bubble from the early 2000s. But, like Amazon, some companies will rise from the ashes.

In the long-run, cannabis survives any upheaval. War, famine, depression, you name it.

But how many of those dot-com companies that once traded alongside Amazon still exist? Do you think that, in the future, people will still be using all the different cryptocurrencies that currently exist? The same way people still use AOL for e-mail or Internet Explorer for a browser?

Cannabis will always be popular. But to imagine a multilayered economy where anyone in the weed business is a millionaire just isn’t going to happen.

Especially in Canada. We’re such a small economy for such a large landmass. The industry will be consolidated by natural forces, but this process will be sped up, unfairly, under current crony-capitalist conditions.

People right now have access to the kind of capital required to start a cannabis business. But in the future, the near future, when capital is scarce, the natural consolidation process will be kicked into high gear, it will be like a clean-up on steroids or a highly potent sativa.

In the end, only a few companies will dominate.

So, where will the others go? And if they’re booted out of the market also due to state prohibition, something that has nothing to do with the natural consolidation process of the market, what then becomes of BC’s booming billion dollar cannabis industry?

The cannabis bubble originates from Ottawa and Bay Street, not BC.

The craft producers of BC are artisans that will survive any recession thrown at them. The stock-trading licensed producers regulated by Ottawa are the ones in trouble.  A few will make it out alive, but even that’s up for debate.

The future of cannabis in Canada looks very much like the dot-com situation from the early 2000s.

Anyone pretending otherwise is deluding themselves.

(Why?)

Published at Thu, 13 Jul 2017 14:33:05 +0000

Read More

CBD research is going to the dogs in quest to help pets

Posted by on in Cannabis | Comments Off on CBD research is going to the dogs in quest to help pets

CBD research is going to the dogs in quest to help pets

CBD research is going to the dogs in quest to help pets

Cannabidiol is a non-psychoactive cannabis compound touted for its medicinal promise — but marijuana- and hemp-derived extracts rich in CBD and low in intoxicating THC are facing a future yet to be determined.

The Cannabist’s special report “CBD, TBD” explores a regulatory and legal landscape pockmarked by federal-state conflicts, and examines national drug policy, pioneering research efforts and disparate avenues toward the compound’s full legalization. This is the fourth installment in an ongoing series.

Part I – Forbidden medicine: Caught between a doctor’s CBD advice and federal laws

Part II – How advocates are inspiring congressional action on CBD legalization

Part III – With DEA digging in its heels on “marijuana extracts,” legality of CBD oil on trial in federal courts


FORT COLLINS — Riley lumbered into the laboratory and greeted scientists with hefty, loving nudges and sloshes of slobber.

The 135-pound Newfoundland is a favorite at the Colorado State University Veterinary Teaching Hospital, where she’s among a few dozen pooches participating in one of the first scientific clinical trials assessing the efficacy of cannabidiol in treating certain canine ailments.

The non-psychoactive cannabis compound isn’t just hailed for its potential medicinal benefits in humans — the anecdotal evidence emerging from legal marijuana states has some pet owners wondering if CBD could be a life-improving medicine for man’s best friend. In Colorado, CBD-rich whole plant hemp extracts already are available for purchase online or at the neighborhood pet shop down the street.

However, scientists and veterinarians caution that clinical research is lacking, dogged by complications — notably marijuana’s Schedule I status and CBD’s shaky legal standing as it relates to another more familiar cannabis compound: psychoactive delta-9 tetrahydrocannabinol (THC), which can be toxic to animals.

CSU veterinary neurologist Dr. Stephanie McGrath began fielding queries about CBD’s therapeutic powers for pets after Colorado legalized recreational marijuana and cultivation of industrial hemp in 2012. Owners and vets alike called to inquire about the safety and efficacy of administering CBD to pups for everything from sore hips, to seizures, to anxiety caused by fireworks and thunderstorms.

What McGrath heard was extremely disappointing, she said. Some pet owners were dosing animals with their own edibles or other medical marijuana products procured to treat human ailments.

“That, as you can imagine, is not safe at all,” she said.

In addition to her concerns with the DIY nature of the dosing, McGrath said she was skeptical of what was being packaged and sold in pet stores. No qualified, peer-reviewed scientific studies had been conducted on CBD products for pets, she realized.

“Looking at it from a scientific standpoint and as a doctor, I felt really uncomfortable with the products being offered,” she said.

Whether it’s THC-laden marijuana or industrial hemp with traces of that illicit compound, cannabis is a Schedule I substance. The uncertain legal landscape surrounding CBD oileven the hemp-derived variety — has stymied studies for humans and animals alike.

Its murky legal status doesn’t just impede access to the whole hemp plant extract, said Michael San Filippo, spokesman for the American Veterinary Medical Association. It also makes it difficult for scientists to receive the blessing — and funding — for CBD research from major academic institutions wary of crossing federal boundaries, he said.

As such, the science isn’t there yet on aspects such as CBD’s effectiveness and dosing, San Filippo said.

“There are a lot of unanswered questions,” he said.

Avoiding the placebo effect

A CSU research team led by McGrath is starting to provide some answers for pet owners and veterinarians.

In March 2016, the CSU team completed work on a safety, toxicity and pharmacokinetic study of CBD in healthy dogs that was the first to demonstrate the compound was measurable in the blood and safe enough to warrant studies in a clinical population.

For the study, 30 research beagles were given high doses of a CBD-rich oil derived from Colorado hemp and produced by Fort Collins-based Applied Basic Science Corp. (ABSC). Of the three dosing methods tested — capsule, tincture and transdermal cream — tincture showed the most promise for safety and measurement in the bloodstream, McGrath said.

Side effects included diarrhea and an elevated liver enzyme, she said, noting that there were no blood test abnormalities that prompted the removal of a dog from the study.

The results, currently under peer review, were enough for CSU to green-light clinical trials.

Last November, CSU researchers began enrolling dogs in two clinical trials measuring the effectiveness of ABSC’s Colorado Hemp Oil, or C.H.O., in treating symptoms of osteoarthritis and epilepsy.

The CSU studies are conducted with a double-blind method, considered the most reliable way to eliminate the power of suggestion since neither the researcher nor the test subject (which, in this case, also includes the pet owner) knows whether they have received a placebo.

McGrath is principal investigator on the epilepsy study while Dr. Felix M. Duerr, a CSU veterinary surgeon, is principal investigator on the arthritis side. By the end of June, CSU had enrolled 20 of 24 arthritis patients and 16 of 34 epilepsy patients.

The stakes are high for McGrath’s double-blind, placebo-controlled epilepsy study. About 30 percent of dogs on conventional anti-convulsant therapies continue to have uncontrolled seizures or experience side effects that are so debilitating that their owners consider it a poor quality of life, she said.

Sometimes those dogs have to be euthanized.

“It’s imperative, really, that we find a drug or drugs that are able to control seizures in dogs — and humans, for that matter,” she said.

Over the course of the 12-week trial, owners maintain a daily seizure log and patients are assessed and subjected to blood tests every four weeks.

The osteoarthritis study is a double-blind crossover, meaning that each dog will receive either a placebo or CBD oil for six weeks and then be “crossed over” to receive the opposite solution for the next six weeks.

Patients are required to walk for 15 minutes daily, and their vitals and activity are monitored by a “doggy Fitbit” collar. Every couple of weeks, the patient must pop into the lab for a gait analysis.

Those types of scientific analyses help to counterbalance any placebo effect that may be coming from the owner, Duerr said.

“We like these clinical studies because it gives us a chance to help individual dogs and also advance veterinary science,” Duerr said.

Enter Riley, the slobbery 3-year-old Newfoundland suffering from a rough bout of arthritis.

“I’ll try whatever I can to help her”

Previous surgeries addressed elbow dysplasia and a torn ACL, but the development of arthritis has slowed Riley down significantly of late. She can’t play for long without needing a rest. Sometimes, she lies down to eat. She cries at night when the pain gets to be too much.

“I’ll try whatever I can to help her,” said Astonna McCoy, Riley’s owner. “She needs to have a life.”

The Loveland resident initially signed up Riley for a stem-cell study at CSU. The treatment relieved her arthritis pain for a few months.

Then, “like a light switch,” it wore off, McCoy said.

That’s when McCoy learned that CSU researchers were beginning clinical trials measuring the effectiveness of CBD in treating symptoms of osteoarthritis.

At first, she was “freaked” to have Riley try any derivative of cannabis. However, the prospects of a long-term solution outweighed the minimal risks conveyed, she said.

“It took me a week or so to get over that, ‘No way in hell I’m going to give this to her,’” she said.

Riley was in the lab in late May to establish her final gait baseline before beginning the osteoarthritis study.


Story continues below photo gallery
Dr. Stephanie McGrath, left, and Dr. Sarah Holman check over results of gait analysis conducted on canine test subject Riley. McGrath, a veterinarian and researcher at Colorado State University’s Veterinary Teaching Hospital, is taking part in clinical trials testing cannabidiol’s effect on epilepsy and osteoarthritis in canines. (Vince Chandler, The Denver Post)

With the help of a research technician, the jovial giant took a few good gallops on a pressure mat measuring her every move. After the session, Riley was rewarded with a treat, which she devoured before slopping up an entire bowl of water.

Researchers will be checking for changes in how Riley uses her right foreleg after the analysis showed forelimb lameness and her shifting weight to accommodate for a bad elbow.

By early July, four weeks into the study, McCoy reported Riley was doing well, but still had her “good days and bad days.”

On some days, the Newfoundland was signaling for walks and playing more with her dog brother Tank, a 95-pound Golden Labrador Retriever. On other days, she was listless and inactive.

“I can’t wait to get to the end of this study to find out (the results),” McCoy said.

McGrath and Duerr said they expect the outcomes of their clinical studies to be available in the next 12 to 18 months.

Hemp companies consider CBD research a key investment

Clinical trials are never cheap; but when the legal ambiguities of CBD are added to the equation, costs — and complications — can skyrocket.

CSU’s studies involving C.H.O. have been funded by producer ABSC.

The safety, toxicity and pharmacokinetic study cost the company $125,000, McGrath said. The two clinical trials are expected to cost the company about $250,000 each. McGrath disclosed she has a 5 percent stake in the company funding the CBD research.

ABSC was founded in December 2015 by New York entrepreneur S. David Moche, but the company held off on selling bottles of C.H.O., a strain-specific hemp extract targeted specifically for the pet market, before the completion of CSU’s preliminary safety study in early 2016.

“If we didn’t do the research,” Moche said, “(selling C.H.O. as a pet product) wouldn’t have been something I would’ve been interested in doing.”

ABSC started selling C.H.O. pet tincture, which it markets as the only scientifically tested product available. But the company isn’t the only player in the pet CBD arena investing in research.

Denver-based Therabis Pet Products, a subsidiary of Dixie Brands, is backing an efficacy study of its hemp-derived CBD products at the University of Pennsylvania School of Veterinary Medicine.

Although Therabis has received positive reception in the consumer and veterinary communities, clinical trials could validate the company’s CBD products, said Chad Reiling, company spokesman.

A Penn Vet spokeswoman declined to comment on the status or funding of the ongoing clinical trial.

For its part, CSU has general counsel and veterinary brass monitoring developments in the ongoing legal saga surrounding hemp-derived CBD oil. The university even developed an FAQ about cannabis-related research to assist scientists and others interested in pursuing the topic.

“I don’t think (a research university) has been in this situation — at least not in my lifetime — and seen this kind of ambiguity,” said Mark Wdowik, CSU’s assistant vice president for research and industry.

The university has seen an increase in hemp- and marijuana-related research requests since legalization, he said. The institution also has fielded more queries from companies seeking to fund CBD studies.

While CSU monitors the cannabis research front, projects such as the two canine clinical trials will continue to progress, Wdowik said.

“CSU is similar to other universities in that we want to be the honest broker,” he said.

ABSC’s Moche echoed the university’s sentiments. His company is operating within the four corners of Colorado law, which allows for some commercialization of hemp.

“We’re not shipping it across state lines. We’re not looking for trouble,” Moche said. “We’re looking to give pet owners a little bit of comfort and pets a little bit of relief.”

(Why?)

Published at Wed, 12 Jul 2017 18:31:13 +0000

Read More

INDVR Lipstick and Mascara vape pens designed with discretion, not feminism, in mind (vaporizer review)

Posted by on in Cannabis | Comments Off on INDVR Lipstick and Mascara vape pens designed with discretion, not feminism, in mind (vaporizer review)

INDVR Lipstick and Mascara vape pens designed with discretion, not feminism, in mind (vaporizer review)

INDVR Lipstick and Mascara vape pens designed with discretion, not feminism, in mind (vaporizer review)

In a cloud of “Do you even vape, bro?” culture, a vaporizer aimed at women is a breath of fresh air.

The lipstick-toting portion of the population has been largely ignored by marijuana product specialization while the industry waits on concrete consumer data to figure out how many — and how — women consume cannabis.

But the writing is on the wall. One ongoing study by market research firm BDS Analytics reports women make up the majority of new consumers in Colorado and California. Meanwhile, a 2016 Gallup poll found that one in eight Americans consumes cannabis; if women comprise just one in four of those consumers, there are more than 10 million lady stoners in the country.

Cannabis is realizing a feminist revolution that, like it or not, is gendering previously non-gendered objects such as the vaporizer.

New Lipstick and Mascara vapes from Colorado-based INDVR are byproducts of this revolution. Their goal? To be hidden in plain sight. The company’s tagline proudly reads, “Sleek, stylish, stealth.” So, do these new vapes offer function to match their form factor?

INDVR Mascara vape (Lindsey Bartlett)
INDVR’s Mascara vape is designed to blend in with the contents of a makeup bag or purse. (Lindsey Bartlett, The Cannabist)

Betting big on stealth

Demand for recreational concentrates grew from 10 percent of sales in 2015 to 21 percent of sales in 2016 fueled in part by a desire for increased discretion, according to cannabis analytics firm New Frontier Data. INDVR is betting big on that desire with its lineup of three vapes sold under the “stealth” message: Elite pen (Executive pen style coming soon), Mascara and Lipstick.

The INDVR packaging is minimalist and the basics are included: one universal USB mini charger and a wall dock. All three of its vapes are sleek and smooth, made with heavy alloy steel topped in black matte. The Mascara and Lipstick retail for a reasonable $60 each, while the Elite pen runs $80.

The Elite is the stealthiest of the three — it writes and almost looks like a Montblanc, except you can use the back end of it as a mouthpiece. Yes, sucking on the end of a pen looks weird and possibly dirty. But unlike the Mascara and Lipstick, you don’t need to take off the lid to hit it. During use, it’s 100 percent disguised as its intended object. Both of INDVR’s makeup-styled vapes look like regular ol’ vape pens when you remove the lids.

INVDR Lipstick vape with cartridge (Lindsey Bartlett, The Cannabist)
INVDR Lipstick vape with a cartridge installed and the lid off. (Lindsey Bartlett, The Cannabist)

And even with their lids on, each of these vapes could easily pass for objects other than makeup. While shopping on a few separate occasions at The Joint in North Denver, the dispensary owned by the entrepreneurs behind INDVR, I heard customers say that the Lipstick looked like a USB drive, a portable phone charger and even a vibrator. It’s a bit larger than a regular lipstick container and shaped weirdly enough to pass for many items that may be in your purse. The Mascara is a better match — the design is stretched longer and it has a gratifying weight in-hand. Be warned: It’s round and will roll off of any flat surface.

The outside appearance of these respective vapes is almost too generic to pass as makeup. The lack of logos and other branding are dead giveaways, but not evident to the untrained eye — i.e., dudes. In fact, the team behind these two makeup vapes are entirely made up of men.

When asked why they chose to create these two vapes for women, INDVR vice president PJ Rinker explained that the company saw a huge women-specific market going untouched.

The Lipstick and Mascara are aimed at the woman “who doesn’t necessarily want to proclaim that she’s a stoner but wants to have that ability to use the product any place, any time, without being ridiculed or thought of as anything less,” he said.

The company is garnering positive female feedback, Rinker said.

“Women love it,” he said. “They love the looks and they love that they can carry it in their clutch or purse and never get questions about it.”

Should you put it in your purse?

INDVR’s aim seems true. Still, the concept that a company owned by men would design these devices may not sit well with some feminist vapists. The implications of such a product are that makeup is all women care about or want, and that women would prefer cute vapes to those that work well.

While those implications are ever-so-slightly problematic, the mere development of these products hints at a positive cultural shift in acceptance of female smokers as more than just Instagram models or Dabbing Granny. Many professional women and cannabis consumers are goddamn pros who don’t have time to mess with sub-par vape pens.

The on-the-go woman may be willing to make sacrifices, though, and even a seasoned pro can find comfort behind the cover of INDVR’s Lipstick and Mascara vape pens. Drop one in your purse as a back-up when traveling, going to shows, or if you’re extra paranoid. Its best asset is indeed its stealth.

INDVR Mascara Vape with cartridge (Lindsey Bartlett, The Cannabist)
The INDVR Mascara with 510 cartridge ready to install. (Lindsey Bartlett, The Cannabist)

Hitting both the Lipstick and Mascara requires a long pull, one that stings slightly to the back of the throat, a feeling I’ve come to expect from even the cleanest of oil cartridges. A slow, long hit will reap plenty of vapor as reward, but it’s not a huge cougher. The initial taste is clean; the aftertaste lingers, and the sting can cause a bit of a scratchy throat if used heavily.

Both makeup vapes fit the standard 510 universal cartridge thread widely available at dispensaries. You’d be wise to buy a cartridge — including mouthpiece — that is short. For instance, O.pen Vape’s 510 cartridges have a longer mouthpiece, so while they fit in Lipstick and Mascara, their length makes it impossible to close the lid. The cartridge recommended by INDVR is sold in their dispensary and just two inches long. It is prefilled with 500 milligrams of oil and retails for $40 pre-tax. It’s worth getting the right sized cartridge for these incognito units, because the most satisfying aspects of these vapes is taking a drag, snapping on the magnet lid, and throwing it back in your bag.

Does the concept of needing to hide your vape come along with an underlying implication of shame? What do these products say about women who are cannabis consumers? Some might say the message is: “Hide who you are from the world in style, ladies. Sure you can smoke but keep it tight, keep it classy.”

There’s no need to wait for the consumer studies to figure out what women want. I can confirm that female vape consumers want the best product possible, regardless of aesthetic appeal and regardless of whether or not looks like something everybody else carries in their purse. Most women vapers I know choose function over form.

The INDVR Lipstick and Mascara vapes are fun, but they feel like female-focused products designed through the male gaze. Yes, each of these vapes provides a good rip in a rush, and either makes for a cool party trick. In the future when cannabis is normalized, we won’t have to hide our vapes in lipstick and mascara casings. Until then, you’re paying for peace of mind with these incognito vaporizers.

Lipstick and Mascara each retail for $60 and are available directly from Indvr.life

Gallery: INDVR Lipstick and Mascara

INDVR’s Mascara vape is designed to blend in with the contents of a makeup bag or purse. (Lindsey Bartlett, The Cannabist)

(Why?)

Published at Mon, 10 Jul 2017 22:06:45 +0000

Read More

Canadian AIDS Society announces Cannabis Research Program

Posted by on in Cannabis | Comments Off on Canadian AIDS Society announces Cannabis Research Program

Canadian AIDS Society announces Cannabis Research Program

Canadian AIDS Society announces Cannabis Research Program

OTTAWA, July 6, 2017 /CNW/ – The Canadian AIDS Society announced today a first of its kind research program funded by Canopy Growth Corporation. The program is designed to provide up-to-date information on the current state of evidence and research pertaining to the use of cannabis for medical purposes and to build tools for healthcare professionals to allow them to confidently assess and prescribe cannabis to appropriate patients.

Funded over two years at $100,000 per year — and guided by a newly created Cannabis Research Task Force of experts in the field of cannabinoid medicine — the project aims to develop guidelines and recommendations regarding the medical use of cannabis for optimal wellness, quality of life and pain management.

“Our goal is to leverage our existing knowledge and expertise in both HIV and the use of cannabis for medical purposes to create a better quality of life for many Canadians facing debilitating health conditions — particularly in the area of chronic pain management,” said Gary Lacasse, Executive Director of the Canadian AIDS Society. “This project builds on a body of existing knowledge and research developed by CAS over several years.”

The Task Force will be addressing issues surrounding the current lack of information — for Canadian health care practitioners and ultimately for patients — regarding guidance on the use of cannabis for medical or therapeutic purposes. It is estimated that 10% of Canadian physicians have written an authorization for medical cannabis.

The Cannabis Research Task Force is expected to review the current state of research for the use of medical cannabis and develop a scope of work for evidence-based Canadian guidelines in such areas as treatment, contraindications, dosing, chronic pain, risk management and regulatory issues, among others.

Fact Sheet
Cannabis Research Program
Funded by Canopy Growth Corporation

In Canada, approximately 75,500 are living with HIV and about 250,000 are living with hepatitis C (HCV).

Cannabis has been proven to be effective to relieve symptoms — including chronic pain management — related to many medical conditions.

The Cannabis Research Task Force brought together by the Canadian AIDS Society is expected to review the current state of research for the use of medical cannabis and develop a scope of work for evidence-based Canadian guidelines in such areas as treatment, contraindications, dosing, chronic pain, risk management and regulatory issues, among others.

About the Canadian AIDS Society (CAS)
The Canadian AIDS Society (CAS) is a national coalition of community-based AIDS organizations across Canada. CAS is dedicated to strengthening the response to HIV/AIDS across all sectors of society, and to enriching the lives of people and communities living with, or affected by, HIV/AIDS. For more information, please visit www.cdnaids.ca.

SOURCE Canopy Growth Corporation

(Why?)

Published at Fri, 07 Jul 2017 00:33:55 +0000

Read More